Common Contracts
2 similar Medical Imaging Services Agreement contracts
ContractMedical Imaging Services Agreement • August 27th, 2024
MEDICAL IMAGING SERVICES AGREEMENT SMLOUVA O POSKYTOVÁNÍ SLUŽEB V OBLASTILÉKAŘSKÉHO ZOBRAZOVÁNÍ AbbVie s.r.o., registered office at Metronom Business Center, Bucharova 2817/13, Stodůlky, 158 00 Praha 5, Czech Republic, ID: 24148725, VAT ID: CZ24148725, registered in the Commercial Register of the Municipal Court in Prague Section C, File No. 183123, represented by Mgr. Jan Balzer, Country Clinical Operations Manager, upon power of attorney (“AbbVie”) desires to retain medical facility Nemocnice Na Homolce, Roentgenova 37/2, 150 30 Praha 5, Czech Republic, ID: 000 23 884, VAT ID: CZ00023884, represented by MUDr. Petr Polouček, MBA (“Service Provider”), for Services (as defined below) pursuant to the terms and conditions of this Medical Imaging Services Agreement ("Agreement"). WHEREAS AbbVie is acting as an authorized agent in Czech Republic of AbbVie Deutschland GmbH & Co. KG, the sponsor of the Study in the European Union as defined in the Regulation (EU) No. 536/2014 respectively Dir
ContractMedical Imaging Services Agreement • July 23rd, 2024
MEDICAL IMAGING SERVICES AGREEMENT SMLOUVA O POSKYTOVÁNÍ SLUŽEB V OBLASTILÉKAŘSKÉHO ZOBRAZOVÁNÍ AbbVie s.r.o., registered office at Metronom Business Center, Bucharova 2817/13, Stodůlky, 158 00 Praha 5, Czech Republic, ID: 24148725, VAT ID: CZ24148725, registered in the Commercial Register of the Municipal Court in Prague Section C, File No. 183123, represented by Mgr. Jan Balzer, Country Clinical Operations Manager, upon power of attorney (“AbbVie”) desires to retain medical facility Nemocnice Na Homolce, Roentgenova 37/2, 150 30 Praha 5, Czech Republic, ID: 000 23 884, VAT ID: CZ00023884, represented by MUDr. Petr Polouček, MBA (“Service Provider”), for Services (as defined below) pursuant to the terms and conditions of this Medical Imaging Services Agreement ("Agreement"). WHEREAS AbbVie is acting as an authorized agent in Czech Republic of AbbVie Deutschland GmbH & Co. KG, the sponsor of the Study in the European Union as defined in the Regulation (EU) No. 536/2014 respectively Dir
